Tender Details
Description / Scope of Work
Jinnah Institute of Cardiology, located in Lahore, Punjab, invites electronic bids for the procurement of drugs and medicines for the financial year 2026-27. This is a comprehensive pharmaceutical procurement tender issued by a premier cardiac healthcare institution. The bidding document details the complete requirements, technical specifications, and contractual terms for supplying quality medicines to the institute. Eligible bidders must be registered pharmaceutical suppliers or authorized distributors in Pakistan with valid registration from relevant regulatory authorities including the Drug Regulatory Authority of Pakistan (DRAP).
Bidders must submit bid security as specified in the tender document, typically a guarantee from a scheduled bank or certified deposit receipt. All submissions must be made electronically through the designated portal before the deadline. Bidders are required to provide documentary evidence of their eligibility, licensing status, past performance credentials, and product quality certifications. Technical specifications and conformity documentation establishing that supplied goods meet declared standards must accompany each bid.
The complete bidding documents are available for download from the Jinnah Institute of Cardiology's procurement portal. Electronic bids must be submitted by 11 November 2026. Bid opening will be conducted as per the schedule outlined in the tender documents. Interested suppliers should carefully review all sections including general conditions of contract, special conditions, schedule of requirements, and technical specifications before preparing their submissions. For clarifications or enquiries, contact the procurement department of Jinnah Institute of Cardiology directly.
For Bidders: Our Analysis PAKISTANTENDER INSIGHT
Independent analysis by PakistanTender, written with AI from the official notice and checked by our quality rules — not part of the official notice. Always confirm details against the original tender document.
Large-scale pharmaceutical procurement by a major cardiac hospital for full financial year supply.
Bidders must hold DRAP registration and demonstrate product quality certifications. The tender requires comprehensive documentation of eligibility and past performance. Tight 2026 timeline suggests well-planned procurement cycle. Scale indicates substantial volume but margin pressure likely from institutional buyer. Recurring annual contract suggests potential for framework renewal if performance is satisfactory.
Who can bid: Bidders typically require DRAP registration for pharmaceutical supply, valid business registration with SECP, active NTN, and bank account standing. No specific PEC category applies; pharmacy suppliers and authorized distributors meeting regulatory standards are eligible. Insurance and performance guarantee capability essential.